Menu
GeneBe

LIG4

DNA ligase 4, the group of DNA ligases

Basic information

Region (hg38): 13:108207438-108218368

Links

ENSG00000174405NCBI:3981OMIM:601837HGNC:6601Uniprot:P49917AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • DNA ligase IV deficiency (Definitive), mode of inheritance: AR
  • Dubowitz syndrome (Supportive), mode of inheritance: AR
  • Omenn syndrome (Supportive), mode of inheritance: AR
  • DNA ligase IV deficiency (Supportive), mode of inheritance: AR
  • DNA ligase IV deficiency (Strong), mode of inheritance: AR
  • DNA ligase IV deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
LIG4 syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiationARAllergy/Immunology/Infectious; Hematologic; OncologicAntiinfectious prophylaxis and early and aggressive treatment of infections and hematologic anomalies may be beneficial; Oncologic disorders have also been described, and surveillance may allow prompt treatmentAllergy/Immunology/Infectious; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic11779494; 15333585; 16088910; 16357942

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LIG4 gene.

  • DNA ligase IV deficiency (535 variants)
  • Severe combined immunodeficiency due to DCLRE1C deficiency (84 variants)
  • not provided (64 variants)
  • Inborn genetic diseases (34 variants)
  • not specified (31 variants)
  • DNA ligase IV deficiency;Multiple myeloma (9 variants)
  • Multiple myeloma;DNA ligase IV deficiency (4 variants)
  • LIG4-Related Disorders (3 variants)
  • prenatal LIG4 syndrome with aqueductal stenosis (3 variants)
  • LIG4-related condition (2 variants)
  • Multiple myeloma, resistance to (2 variants)
  • Multiple myeloma (1 variants)
  • Severe combined immunodeficiency disease (1 variants)
  • Papillary thyroid carcinoma (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIG4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
123
clinvar
4
clinvar
133
missense
5
clinvar
9
clinvar
287
clinvar
8
clinvar
4
clinvar
313
nonsense
12
clinvar
3
clinvar
15
start loss
0
frameshift
29
clinvar
5
clinvar
3
clinvar
37
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
20
clinvar
11
clinvar
14
clinvar
45
Total 46 17 319 142 22

Highest pathogenic variant AF is 0.000342

Variants in LIG4

This is a list of pathogenic ClinVar variants found in the LIG4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-108207452-G-A DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Benign (Jan 12, 2018)310947
13-108207498-C-T DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Benign (Jan 12, 2018)310948
13-108207550-C-T Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Benign (Jan 12, 2018)310949
13-108207627-A-T Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 13, 2018)310950
13-108207676-A-G Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 12, 2018)881611
13-108207677-T-TAAAA DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Likely benign (Jun 14, 2016)310951
13-108207707-T-A DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Benign (Jan 13, 2018)310952
13-108207752-T-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jan 13, 2018)882771
13-108207795-C-T Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 13, 2018)310953
13-108207797-G-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jan 13, 2018)882772
13-108207848-A-G Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Benign (Jan 13, 2018)882773
13-108207856-T-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Benign (Jan 12, 2018)310954
13-108207903-CCAATT-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jun 14, 2016)310955
13-108207919-T-G Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Likely benign (Jan 13, 2018)310956
13-108207930-TTAAG-T Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Likely benign (Jun 14, 2016)310957
13-108207970-C-CATT Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Likely benign (Jun 14, 2016)310958
13-108208008-A-C Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 13, 2018)883558
13-108208047-T-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jan 12, 2018)310959
13-108208181-T-G DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jan 13, 2018)310960
13-108208227-T-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain significance (Jan 13, 2018)310961
13-108208242-T-C Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 13, 2018)881190
13-108208248-T-C Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 12, 2018)310962
13-108208291-T-C Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 13, 2018)310963
13-108208329-T-C DNA ligase IV deficiency • Severe combined immunodeficiency due to DCLRE1C deficiency Benign (Jul 07, 2018)310964
13-108208367-C-G Severe combined immunodeficiency due to DCLRE1C deficiency • DNA ligase IV deficiency Uncertain significance (Jan 12, 2018)310965

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LIG4protein_codingprotein_codingENST00000356922 110930
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000004160.99112557901681257470.000668
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2024614730.9740.00002436070
Missense in Polyphen89117.940.754641487
Synonymous-0.3131641591.030.000007971695
Loss of Function2.331325.80.5040.00000144382

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002080.00208
Ashkenazi Jewish0.0001990.000198
East Asian0.0003260.000326
Finnish0.00004660.0000462
European (Non-Finnish)0.0007920.000791
Middle Eastern0.0003260.000326
South Asian0.0005880.000588
Other0.0008170.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Efficiently joins single-strand breaks in a double- stranded polydeoxynucleotide in an ATP-dependent reaction. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The LIG4-XRCC4 complex is responsible for the NHEJ ligation step, and XRCC4 enhances the joining activity of LIG4. Binding of the LIG4-XRCC4 complex to DNA ends is dependent on the assembly of the DNA- dependent protein kinase complex DNA-PK to these DNA ends. {ECO:0000269|PubMed:10854421, ECO:0000269|PubMed:9809069}.;
Disease
DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]: A form of severe combined immunodeficiency, a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T- cell-mediated cellular immunity due to a defect in T-cell development. Individuals affected by RS-SCID show defects in the DNA repair machinery necessary for coding joint formation and the completion of V(D)J recombination. A subset of cells from such patients show increased radiosensitivity. {ECO:0000269|PubMed:16357942}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Non-homologous end-joining - Homo sapiens (human);DNA Repair;Disease;Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair;HIV Life Cycle;HIV Infection;2-LTR circle formation;Infectious disease;DNA-PK pathway in nonhomologous end joining;Integration of provirus;Early Phase of HIV Life Cycle (Consensus)

Recessive Scores

pRec
0.100

Intolerance Scores

loftool
0.531
rvis_EVS
-0.39
rvis_percentile_EVS
27.05

Haploinsufficiency Scores

pHI
0.404
hipred
Y
hipred_score
0.608
ghis
0.573

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.700

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lig4
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm;

Zebrafish Information Network

Gene name
lig4
Affected structure
double-strand break repair via alternative nonhomologous end joining
Phenotype tag
abnormal
Phenotype quality
increased process quality

Gene ontology

Biological process
single strand break repair;in utero embryonic development;pro-B cell differentiation;DNA replication;DNA ligation;nucleotide-excision repair, DNA gap filling;double-strand break repair;double-strand break repair via nonhomologous end joining;cell cycle;central nervous system development;cell population proliferation;response to X-ray;response to gamma radiation;T cell differentiation in thymus;V(D)J recombination;immunoglobulin V(D)J recombination;T cell receptor V(D)J recombination;somatic stem cell population maintenance;negative regulation of neuron apoptotic process;isotype switching;positive regulation of fibroblast proliferation;positive regulation of neurogenesis;DNA ligation involved in DNA recombination;DNA ligation involved in DNA repair;chromosome organization;cell division;neuron apoptotic process;cellular response to lithium ion;cellular response to ionizing radiation;DNA biosynthetic process;establishment of integrated proviral latency;double-strand break repair via classical nonhomologous end joining;positive regulation of chromosome organization
Cellular component
nuclear chromosome, telomeric region;condensed chromosome;nucleus;nucleoplasm;DNA-dependent protein kinase-DNA ligase 4 complex;DNA ligase IV complex;cytoplasmic ribonucleoprotein granule;nonhomologous end joining complex
Molecular function
DNA binding;DNA ligase activity;DNA ligase (ATP) activity;protein binding;ATP binding;protein C-terminus binding;ligase activity;metal ion binding